Stonepine Capital Management’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,965,865
Closed -$8.2M 23
2023
Q3
$8.2M Buy
7,965,865
+6,465,865
+431% +$8.26M 2.73% 9
2023
Q2
$2.9M Buy
+1,500,000
New +$2.58M 1.04% 17
2021
Q4
Sell
-1,724,201
Closed -$6.76M 35
2021
Q3
$6.76M Buy
1,724,201
+1,280,694
+289% +$6.4M 3.08% 10
2021
Q2
$2.84M Buy
443,507
+198,992
+81% +$1.37M 1.49% 17
2021
Q1
$1.98M Sell
244,515
-134,955
-36% -$1.24M 1.07% 20
2020
Q4
$3.18M Buy
+379,470
New +$2.57M 2.44% 13

Other funds holding GMDA

Stonepine Capital Management's GMDA Position: Q4 2023 in Review

Stonepine Capital Management sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q4 2023, closing a stake of 7,965,865 shares — an estimated $8.2M sold.

Stonepine Capital Management first reported a position in GMDA in Q4 2020 and held it in 6 quarters. The position peaked at $8.2M in Q3 2023. 52 funds tracked by Wall St. Rank hold GMDA as of Q4 2023.

  • Stonepine Capital Management reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Stonepine Capital Management sold 7,965,865 Gamida Cell Ltd. Ordinary Shares shares in Q4 2023, an estimated $8.2M.
  • Stonepine Capital Management first reported a position in Gamida Cell Ltd. Ordinary Shares in Q4 2020 and held it in 6 quarters.
  • Stonepine Capital Management's Gamida Cell Ltd. Ordinary Shares position peaked at $8.2M in Q3 2023.
  • 52 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q4 2023.

Based on Stonepine Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.